Tarleton welcomes new client VentriJect
VentriJect, a Danish medical device company with operations across the Denmark, Germany and the UK, has appointed Tarleton Communications to handle its European wide public relations.
VentriJect has developed a unique device-software platform that can accurately estimate VO2 max in under three minutes and without the need for exercise using seismocardiography techniques and a proprietary algorithm developed at Aalborg University in Denmark.
The company’s technology could radically change the preventative health sector and has huge potentially in the wellness and fitness sectors too.
“VentriJect are a hugely impressive company and we’re very excited to be part of their journey as they continue to expand across Europe. Tarleton has significant experience across the health and wellness sectors, making us a natural fit and a great partner to help them raise their profile across the sector as they continue to grow. I look forward to continuing to work with the whole team.”